Reuters logo
BRIEF-Bayer says new data affirm effectiveness of Xarelto as therapy for DVT
June 24, 2013 / 6:37 AM / 4 years ago

BRIEF-Bayer says new data affirm effectiveness of Xarelto as therapy for DVT

FRANKFURT, June 24 (Reuters) - Bayer AG : * Says new data affirm Xarelto effectiveness as single-drug therapy for the

treatment of pulmonary embolism and deep vein thrombosis

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below